Unable to secure additional financing amid a stormy market, Tempest Therapeutics has put a call out for partners as it seeks ...

The Trump administration’s effort to slash federal funding to universities has found its latest targets, with the government ...

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

On Friday, a federal judge permanently blocked the National Institutes of Health from implementing indirect cost caps on ...

Big Pharma-backed Atalanta Therapeutics is ramping up for the clinical debut of the company’s lead epilepsy asset in the wake of new data showing the RNA therapy ...

Oncology health tech firm Flatiron Health will use Massive Bio’s patient database to identify and recruit participants for ...

Caris Life Sciences has collected $168 million in new funding to support the growth of its precision medicine platforms, ...

Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating ...

With two attempts to merge with other companies having collapsed, Vincerx Pharma has been left with no choice but to ...

In the latest of a string of clawbacks, the Department of Health and Human Services (HHS) is now sharing plans to cut ...

Researchers combined a vaccine and a probiotic supplement to tend the microbial garden inside the intestines of mice, ...

Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...